Is the shielding effect of cholecalciferol in SARS CoV-2 infection dependable? An evidence based unraveling
Despite being announced as a global health concern and emergency in January by WHO, designing specific treatment for SARS-CoV-2 is still a summit yet to be conquered. Currently, many drugs are being tested in the clinical scenario and vitamins play a significant role in therapeutic management. Based...
- Autores:
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/15313
- Acceso en línea:
- https://doi.org/10.1016/j.cegh.2020.10.005
http://hdl.handle.net/20.500.12010/15313
- Palabra clave:
- Cathelicidin
Latitude
Influenza
Pneumonia
Diabetes
Hypertension
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
- Rights
- License
- Abierto (Texto Completo)